Skip to main content
TipRanks
Go Ultimate75% OFF

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Q3 2022 Earnings Report

0 Followers

JP:4886 Q3 2022 EPS Results

Actual EPS
JPY 65.01
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
JPY 242.28

JP:4886 Q3 2022 Revenue Results

Actual Revenue
JPY 17.09B
Expected Revenue
JPY 16.83B
Beat/Miss
Beat by +JPY 259.00M
YoY Revenue Growth
+8.82%

Earnings Announcement Details

Quarter
Q3 2022
Date
02/06/2023
Time
TBA
Conference Call
Monday, February 6, 2023
JP:4886 Upcoming Earnings

ASKA Pharmaceutical Holdings Co., Ltd.'s next earnings date is estimated for February 8, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

JP:4886 Earnings History

JP:4886 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 08, 20272026 (Q3)―-59.1――
Nov 04, 20262026 (Q2)―51.8534.6149.81% (+17.24)
Aug 04, 20262026 (Q1)―18.7843.88-57.20% (-25.10)
May 11, 20262025 (Q4)―53.5335.3651.39% (+18.17)
Feb 02, 20262025 (Q3)―59.1054.238.98% (+4.87)
Nov 04, 20252025 (Q2)―34.6145.41-23.78% (-10.80)
Aug 04, 20252025 (Q1)―43.8844.95-2.38% (-1.07)
May 12, 20252024 (Q4)―35.3638.37-7.84% (-3.01)
Feb 03, 20252024 (Q3)―54.2382.2-34.03% (-27.97)
Nov 05, 20242024 (Q2)89.5045.4195.42-52.41% (-50.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed